An Overview of Testicular Germ Cell Tumors

Total Page:16

File Type:pdf, Size:1020Kb

An Overview of Testicular Germ Cell Tumors An Overview of Testicular Germ Cell Tumors Armita Bahrami, MD; Jae Y. Ro, MD, PhD; Alberto G. Ayala, MD ● Context.—More than 90% of testicular neoplasms orig- not occur before 5 years of age. Spermatocytic seminoma, inate from germ cells. Testicular germ cell tumors (GCTs) a tumor of elderly men, typically has an indolent clinical are a heterogeneous group of neoplasms with diverse his- behavior, but rarely it undergoes sarcomatous transfor- topathology and clinical behavior. mation associated with an aggressive behavior. Embryonal Objective.—To help the readers distinguish various sub- carcinoma is the most common component in mixed GCTs. types of GCTs, to highlight the clinical manifestations and Eighty percent or more of embryonal carcinoma compo- pathologic features of these tumors, and to review several nent and vascular invasion are recognized predictors of newly developed immunohistochemical markers for GCTs. occult metastasis for clinical stage I mixed GCTs. Most pa- Data Sources.—Review of the pertinent literature and tients with prepubertal yolk sac tumor, the most common our experience. pediatric GCT, have stage I disease at presentation. Most Conclusions.—The etiology of GCTs is largely unknown. choriocarcinomas present with metastatic symptoms be- Cytogenetic studies suggest a different pathogenesis for cause of the propensity for rapid hematogenous dissemi- each group of infantile/prepubertal GCTs, postpubertal nation. Teratomas in children regardless of maturity and GCTs, and spermatocytic seminoma. Unclassified intratu- dermoid cysts in adults are benign; in contrast, teratomas bular germ cell neoplasia is the precursor of all GCTs, ex- in adults have a malignant behavior. With appropriate ther- cluding spermatocytic seminoma and infantile/prepubertal apy, the majority of testicular GCTs are curable. GCTs. Seminoma, the most common GCT in adults, does (Arch Pathol Lab Med. 2007;131:1267–1280) esticular tumors are the most common malignancies vealed an increase in the incidence of GCTs during the T among American men between the ages of 20 and 39 past several decades,10,11 but the reason for such a trend is years.1,2 The American Cancer Society has estimated that unclear. in the year 2006, 8250 men will develop testicular cancers Testicular GCTs are a heterogeneous group of neo- and 370 men will die of these tumors in the United States.3 plasms with diverse histopathology and variable clinical Testis tumors comprise approximately 1% of all cancers in course and prognosis. This diversity is best reflected in men,3,4 but only about 0.1% of cancer deaths in males3 be- various systems offered to classify these tumors.12–17 Cur- cause the majority of these tumors are curable.5 rently the most comprehensive and widely accepted sys- More than 90% of testicular neoplasms originate from tem of classification is the one proposed by the World 6 germ cells. The incidence of testicular germ cell tumors Health Organization,18 which is summarized in Table 1. (GCTs) increases shortly after the onset of puberty and There is some evidence that the origin and biology of peaks in the fourth decade of life with a median age of prepubertal and postpubertal testicular GCTs are distinct 7 34 years at diagnosis. The incidence varies among differ- from each other. First, the distribution pattern of GCTs in ent races and various geographic locations. It is 5 times adults and children is different. Testicular neoplasms in more frequent in white men compared with African 8 adult patients often consist of seminoma, embryonal car- American men. Among nations with the highest reported cinoma, or mixed testicular GCTs. In the pediatric popu- incidence are Scandinavia, Germany, and New Zealand.9 lation, yolk sac tumor and teratoma are the most frequent Despite several recognized risk factors in the develop- tumors; on the contrary, seminoma and embryonal carci- ment of GCTs (eg, cryptorchidism or a prior history of noma are rare.19 Non-GCTs, which account for less than GCT), the pathogenesis of germ cell neoplasms including 10% of testicular neoplasms in adults, comprise as high as the contributing role of environmental factors or genetic susceptibility remains unknown. Reports from the epide- one third of testis tumors in children. Furthermore, al- miologic studies in the United States and Europe have re- though there is a strong association between postpubertal testicular tumors and intratubular germ cell neoplasia, such association has not been observed in prepubertal Accepted for publication November 20, 2006. GCTs. From the Departments of Pathology, Baylor College of Medicine (Dr Genetic studies have shown that postpubertal testis tu- Bahrami), and Weill Medical College of Cornell University, The Meth- mors are often aneuploid with a consistent chromosomal odist Hospital (Drs Ro and Ayala), Houston, Tex. abnormality composed of a gain of short arm of chro- The authors have no relevant financial interest in the products or mosome 12, usually in the form of an isochromosome, companies described in this article. 20 Reprints: Alberto G. Ayala, MD, Department of Pathology, The Meth- i(12p). In contrast tumors arising in prepubertal gonads odist Hospital, Weill Medical College of Cornell University, 6565 Fan- are typically unassociated with 12p amplification and tend nin St, Houston, TX 77030 (e-mail: [email protected]). to be diploid. For these reasons, testicular GCTs have been Arch Pathol Lab Med—Vol 131, August 2007 An Overview of Testicular Germ Cell Tumors—Bahrami et al 1267 Table 1. 2004 World Health Organization Histologic cell neoplasia (eg, intratubular embryonal carcinoma or Classification of Germ Cell Testis Tumors intratubular yolk sac tumor). Intratubular germ cell neo- plasia, unclassified, is known to be the precursor of most Intratubular germ cell neoplasia, unclassified adult GCTs; on the other hand, other types of intratubular ● Tumors of 1 histologic type (pure forms) germ cell neoplasia are developed as an outcome of pag- ● Seminoma ● etoid intratubular spread of their invasive counterpart in Seminoma with syncytiotrophoblastic cells the testicular parenchyma adjacent to a preexisting GCT. ● Spermatocytic seminoma ● Spermatocytic seminoma with sarcoma ● Embryonal carcinoma Pathologic Features ● Yolk sac tumor ● Testes with IGCNU are usually normal in size but can Trophoblastic tumors be smaller than normal. Histologically, IGCNU is charac- ● Choriocarcinoma ● Trophoblastic neoplasms other than choriocarcinoma terized by large primitive atypical cells that are usually ● Monophasic choriocarcinoma twice the size of normal germ cells. These cells lie along ● Placental site trophoblastic tumor the thickened basement membrane of atrophic seminifer- ● Teratoma ous tubules (Figure 1) or may replace the entire tubules. ● Dermoid cyst ● The malignant germ cells have large nuclei with promi- Monodermal teratoma nent nucleoli and abundant clear cytoplasm that is rich in ● Teratoma with somatic type malignancies glycogen, demonstrable by a periodic acid–Schiff (PAS) ● Tumors of more than 1 histologic type (mixed forms) stain. Because normal germ cells are not stained with PAS, ● Mixed embryonal carcinoma and teratoma ● this stain may help to distinguish IGCNU cells from nor- Mixed teratoma and seminoma mal cells. ● Choriocarcinoma and teratoma/embryonal carcinoma ● Others Immunoprofile Most IGCNU cells stain for placental-like alkaline phos- also divided into 3 biologically distinct categories of in- phatase (PLAP)37–40 usually with a membranous and cy- fantile/prepubertal GCTs, postpubertal GCTs, and sper- toplasmic pattern. Placental-like alkaline phosphatase is matocytic seminoma. Spermatocytic seminoma is a dis- an enzyme that in addition to IGCNU is present in em- ease of elderly men and appears to have a different path- bryonal carcinoma, seminoma, and several other GCTs but ogenesis than seminoma. is usually absent in normal germ cells. The IGCNU cells Germ cell tumors have been traditionally separated into are also positive for c-Kit (CD117)41,42 and p53 but are neg- seminomatous and nonseminomatous tumors. This divi- ative for cytokeratins, human chorionic gonadotropin ␣ sion, however, is essentially for clinical purposes because (hCG), or -fetoprotein (AFP). OCT3/4, also known as of some differences in the management approach and POU5F1, is a recently recognized marker for GCTs.43 In prognosis of these 2 groups of tumors. adult testis, positive immunostaining for OCT3/4 is an indicator for the presence of IGCNU, seminoma, and/or INTRATUBULAR GERM CELL NEOPLASIA, embryonal carcinoma.44 OCT3/4 immunostain highlights UNCLASSIFIED IGCNU with a nuclear staining pattern and has proved to There is convincing evidence that intratubular germ cell be a sensitive and specific marker for detection of IGCNU 44,45 neoplasia, unclassified (IGCNU), is the precursor of all in- in biopsy specimens. D2-40, an antibody raised against vasive GCTs with the exception of spermatocytic semi- a transmembrane mucoprotein called podoplanin, stains 46–48 noma and infantile/prepubertal GCTs.21,22 Intratubular IGCNU cells (Figure 2) as well as lymphatics. There- germ cell neoplasia, unclassified, has been identified in the fore, this antibody can be used to confirm the presence or vicinity of GCTs in about 90% of cases.23,24 Additionally, absence of IGCNU adjacent to invasive GCTs and also to there is an increased prevalence of IGCNU in clinical con- highlight lymphatic invasion. ditions at risk for testicular cancer, including cryptorchi- Clinical Course and Management
Recommended publications
  • PROSTATE and TESTIS PATHOLOGY “A Coin Has Two Sides”, the Duality of Male Pathology
    7/12/2017 PROSTATE AND TESTIS PATHOLOGY “A Coin Has Two Sides”, The Duality Of Male Pathology • Jaime Furman, M.D. • Pathology Reference Laboratory San Antonio. • Clinical Assistant Professor Departments of Pathology and Urology, UT Health San Antonio. Source: http://themoderngoddess.com/blog/spring‐equinox‐balance‐in‐motion/ I am Colombian and speak English with a Spanish accent! o Shannon Alporta o Lindsey Sinn o Joe Nosito o Megan Bindseil o Kandace Michael o Savannah McDonald Source: http://www.taringa.net/posts/humor/7967911/Sindrome‐de‐la‐ Tiza.html 1 7/12/2017 The Prostate Axial view Base Apex Middle Apex Sagittal view Reference: Vikas Kundra, M.D., Ph.D. , Surena F. Matin, M.D. , Deborah A. Kuban, M.Dhttps://clinicalgate.com/prostate‐cancer‐4/ Ultrasound‐guided biopsy following a specified grid pattern of biopsies remains the standard of care. This approach misses 21% to 28% of prostate cancers. JAMA. 2017;317(24):2532‐2542. http://www.nature.com/nrurol/journal/v10/n12/abs/nrurol.2013.195.html Prostate Pathology Inflammation / granulomas Categories Adenosis, radiation, atrophy seminal vesicle Biopsy Benign TURP HGPIN Unsuspected carcinoma is seen in 12% of Atypical IHC TURP cases. glands Prostatectomy Subtype, Gleason, Malignant fat invasion, vascular invasion Other malignancies: sarcomas, lymphomas Benign Prostate Remember Malignant Glands Lack Basal Glands Cells Basal cells Secretory cells Stroma 2 7/12/2017 Benign Prostatic Lesions Atrophy Corpora amylacea (secretions) Seminal Vesicle Acute inflammation GMS Basal cell hyperplasia Basal cell hyperplasia Granulomas (BPH) (BPH) coccidiomycosis Mimics of Prostate Carcinoma Atrophy. Benign Carcinoma with atrophic features Prostate Carcinoma 1. Prostate cancer is the most common, noncutaneous cancer in men in the United States.
    [Show full text]
  • Cytokeratin 7, Inhibin, and P63 in Testicular Germ Cell Tumor: Superior Markers of Choriocarcinoma Compared to Β-Human Chorionic Gonadotropin☆ Sonya J
    Human Pathology (2019) 84,254–261 www.elsevier.com/locate/humpath Original contribution Cytokeratin 7, inhibin, and p63 in testicular germ cell tumor: superior markers of choriocarcinoma compared to β-human chorionic gonadotropin☆ Sonya J. Wegman BS, Anil V. Parwani MD, PhD, MBA, Debra L. Zynger MS, MD⁎ Department of Pathology, The Ohio State University Medical Center, Columbus, OH 43210, USA Received 22 August 2018; revised 2 October 2018; accepted 11 October 2018 Keywords: Summary Choriocarcinoma can be difficult to differentiate from other subtypes of testicular germ cell tumor Testicle; and can occur unexpectedly in a distant, late metastasis. The aim of this investigation was to identify a marker Germ cell tumor; superior to β-human chorionic gonadotropin (β-hCG) for choriocarcinoma. Sixty-two primary and metastatic Choriocarcinoma; testicular germ cell tumors (27 choriocarcinomas, 19 yolk sac tumors, 29 embryonal carcinomas, 28 semino- CK7; mas, 22 teratomas, 3 epithelioid trophoblastic tumors [ETTs]) were analyzed for immunohistochemical expres- Inhibin; sion of cytokeratin 7 (CK7), inhibin, p63, and β-hCG. All choriocarcinomas and ETTs were strongly positive p63; for CK7, whereas seminomas were negative and 52% of embryonal carcinomas had weak reactivity. Eighty- β-hCG four percent of yolk sac tumors and 59% of teratomas were CK7 positive. Eighty-nine percent of choriocarci- nomas and 100% of ETTs were positive for inhibin, with reactivity highlighting syncytiotrophoblasts, whereas seminomas, embryonal carcinomas, yolk sac tumors, and teratomas were negative. Eighty-five percent of cho- riocarcinomas expressed p63, with staining mostly in mononucleated trophoblasts, whereas seminomas, em- bryonal carcinomas, and yolk sac tumors were negative.
    [Show full text]
  • Testicular Mixed Germ Cell Tumors
    Modern Pathology (2009) 22, 1066–1074 & 2009 USCAP, Inc All rights reserved 0893-3952/09 $32.00 www.modernpathology.org Testicular mixed germ cell tumors: a morphological and immunohistochemical study using stem cell markers, OCT3/4, SOX2 and GDF3, with emphasis on morphologically difficult-to-classify areas Anuradha Gopalan1, Deepti Dhall1, Semra Olgac1, Samson W Fine1, James E Korkola2, Jane Houldsworth2, Raju S Chaganti2, George J Bosl3, Victor E Reuter1 and Satish K Tickoo1 1Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA; 2Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA and 3Department of Internal Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA Stem cell markers, OCT3/4, and more recently SOX2 and growth differentiation factor 3 (GDF3), have been reported to be expressed variably in germ cell tumors. We investigated the immunohistochemical expression of these markers in different testicular germ cell tumors, and their utility in the differential diagnosis of morphologically difficult-to-classify components of these tumors. A total of 50 mixed testicular germ cell tumors, 43 also containing difficult-to-classify areas, were studied. In these areas, multiple morphological parameters were noted, and high-grade nuclear details similar to typical embryonal carcinoma were considered ‘embryonal carcinoma-like high-grade’. Immunohistochemical staining for OCT3/4, c-kit, CD30, SOX2, and GDF3 was performed and graded in each component as 0, negative; 1 þ , 1–25%; 2 þ , 26–50%; and 3 þ , 450% positive staining cells. The different components identified in these tumors were seminoma (8), embryonal carcinoma (50), yolk sac tumor (40), teratoma (40), choriocarcinoma (3) and intra-tubular germ cell neoplasia, unclassified (35).
    [Show full text]
  • About Testicular Cancer Overview and Types
    cancer.org | 1.800.227.2345 About Testicular Cancer Overview and Types If you have been diagnosed with testicular cancer or are worried about it, you likely have a lot of questions. Learning some basics is a good place to start. ● What Is Testicular Cancer? Research and Statistics See the latest estimates for new cases of testicular cancer and deaths in the US and what research is currently being done. ● Key Statistics for Testicular Cancer ● What’s New in Testicular Cancer Research? What Is Testicular Cancer? Cancer starts when cells begin to grow out of control. Cells in nearly any part of the body can become cancer and spread to other parts of the body. To learn more about how cancers start and spread, see What Is Cancer?1 Cancer that starts in the testicles is called testicular cancer. To understand this cancer, it helps to know about the normal structure and function of the testicles. 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 What are testicles? Testicles (also called testes; a single testicle is called a testis) are part of the male reproductive system. The 2 organs are each normally a little smaller than a golf ball in adult males. They're held within a sac of skin called the scrotum. The scrotum hangs under the base of the penis. Testicles have 2 main functions: ● They make male hormones (androgens) such as testosterone. ● They make sperm, the male cells needed to fertilize a female egg cell to start a pregnancy. Sperm cells are made in long, thread-like tubes inside the testicles called seminiferous tubules.
    [Show full text]
  • Leydig Cell Tumour
    Non-germ cell tumours of the testis Testis: non-germ cell tumours . Sex cord-stromal tumours Dr Jonathan H Shanks . Haemolymphoid neoplasms . Other neoplasms The Christie NHS . Tumour-like conditions Foundation Trust, Manchester, UK . Metastases The Christie NHS Foundation Trust The Christie NHS Foundation Trust Testis: sex cord-stromal tumours . Leydig cell tumour . Sertoli cell tumour, NOS . Sclerosing Sertoli cell tumour . Large cell calcifying Sertoli cell tumour . Granulosa cell tumour, adult-type . Juvenile granulosa cell tumour . Fibroma . Brenner tumour . Sertoli-Leydig cell tumours (exceptionally rare in testis) Leydig cell tumour . Sex cord-stromal tumour, unclassified . Mixed germ cell-sex cord stromal tumour - gonadoblastoma - unclassified (some may be sex cord stromal tumours with entrapped germ cells – see Ulbright et al., 2000) - collision tumour The Christie NHS Foundation Trust The Christie NHS Foundation Trust Differential diagnosis of Leydig cell TTAGS tumour . Testicular tumour of adrenogenital syndrome (TTAGS) . Multifocal/bilateral lesions (especially in a child/young adult) . Seen in patients with congenital adrenal hyperplasia . Leydig cell hyperplasia (<5mm) . 21 hydroxylase deficience most common . Large cell calcifying Sertoli cell tumour . Elevated serum ACTH . Sertoli cell tumour . Seminoma (rare cases with cytoplasmic clearing) . Benign lesion treated with steroids; partial orchidectomy reserved for steroid unresponsive cases . Mixed sex cord stromal tumours . Sex cord stromal tumour unclassified . Fibrous bands; lipofuscin pigment ++; nuclear pleomorphism but no mitosis . Metastasis e.g. melanoma The Christie NHS Foundation Trust The Christie NHS Foundation Trust Immunohistochemistry of testicular Histopathological and immunophenotypic features of testicular tumour of adrenogenital Leydig cell tumour syndrome Wang Z et al. Histopathology 2011;58:1013-18 McCluggage et al Amin, Young, Scully .
    [Show full text]
  • Bilateral Testicular Metastasis from Prostatic Adenocarcinoma Mimicking an Intertubular Pattern of Seminoma and Expressing Rhamm
    Free full text available from Case Report www.cancerjournal.net Bilateral testicular metastasis from prostatic adenocarcinoma mimicking an intertubular pattern of seminoma and expressing Rhamm ABSTRACT Santosh Menon, Adenocarcinoma of prostate metastasizing to testis is a rare occurrence and is incidentally detected in orchiectomy specimens. The pattern Sumeet Gujral, Ganesh Bakshi1, of metastasis may mimic a primary neoplasm of testis like a seminoma or lymphoma and pose a diagnostic difficulty for the pathologist. Hemant B. Tongaonkar1 A rare case of bilateral testicular metastasis of prostatic adenocarcinoma is presented wherein the metastatic cells expressed CD168, a receptor for hyaluronan mediated motility (Rhamm), implicated in the development of androgen independence in prostate cancer. Departments of Pathology, and 1Urologic Surgical Oncology, Tata Memorial Hospital, Parel, Mumbai- KEY WORDS: CD168, metastasis, prostatic adenocarcinoma, testis 400 012, India For correspondence: Dr. Santosh Menon, INTRODUCTION Oncology department of our tertiary Cancer Department of Pathology, Tata Memorial Hospital, Center with history of backache and difficulty in Parel, Mumbai - 400 012, Prostatic adenocarcinoma is one of the commonest micturition since six months. The serum prostate India. malignancies afflicting the adult male population. specific antigen (PSA) at presentation was 173.433 E-mail: santosh.menon@ rediffmail.com The favored sites of metastasis of prostatic ng / ml and serum alkaline phosphatase level was cancer are the bone,
    [Show full text]
  • Treating Testicular Cancer If You’Ve Been Diagnosed with Testicular Cancer, Your Treatment Team Will Discuss Your Options with You
    cancer.org | 1.800.227.2345 Treating Testicular Cancer If you’ve been diagnosed with testicular cancer, your treatment team will discuss your options with you. It’s important to weigh the benefits of each treatment option against the possible risks and side effects. How is testicular cancer treated? Depending on the type and stage of the cancer, as well as other factors, treatment options for testicular cancer can include: ● Surgery for Testicular Cancer ● Radiation Therapy for Testicular Cancer ● Chemotherapy for Testicular Cancer ● High-Dose Chemotherapy and Stem Cell Transplant for Testicular Cancer Common treatment approaches In recent years, a lot of progress has been made in treating testicular cancer. Surgical methods have been refined, and doctors know more about the best ways to use chemotherapy and radiation to treat different types of testicular cancer. In some cases, more than one of type of treatment might be used. ● Treatment Options for Testicular Cancer, by Type and Stage Who treats testicular cancer? You may have different types of doctors on your treatment team, depending on the stage of your cancer and your treatment options. These doctors may include: 1 ____________________________________________________________________________________American Cancer Society cancer.org | 1.800.227.2345 ● A urologist: a surgeon who specializes in treating diseases of the urinary system and male reproductive system ● A radiation oncologist: a doctor who treats cancer with radiation therapy ● A medical oncologist: a doctor who treats cancer with medicines like chemotherapy You might have many other specialists on your treatment team as well, including physician assistants, nurse practitioners, nurses, nutrition specialists, social workers, and other health professionals.
    [Show full text]
  • Testicular Seminomatous Mixed Germ Cell Tumor with Choriocarcinoma
    Aneja et al. Journal of Medical Case Reports 2014, 8:1 JOURNAL OF MEDICAL http://www.jmedicalcasereports.com/content/8/1/1 CASE REPORTS CASE REPORT Open Access Testicular seminomatous mixed germ cell tumor with choriocarcinoma and teratoma with secondary somatic malignancy: a case report Amandeep Aneja1*, Siddharth Bhattacharyya1, Jack Mydlo2 and Susan Inniss1 Abstract Introduction: Testicular tumors are a heterogeneous group of neoplasms exhibiting diverse histopathology and can be classified as seminomatous and non-seminomatous germ cell tumor types. Mixed germ cell tumors contain more than one germ cell component and various combinations have been reported. Here, we present a rare case of a mixed germ cell tumor composed of seminoma, choriocarcinoma and teratoma with a secondary somatic malignancy. Case presentation: A 31-year-old Caucasian man presented with splenic rupture to our hospital. A right-sided testicular swelling had been present for 6 months and his alpha-fetoprotein, beta-human chorionic gonadotropin, and lactose dehydrogenase were increased. An ultrasound of his scrotum revealed an enlarged right testis with heterogeneous echogenicity. Multiple hypervascular lesions were noted in his liver and spleen. He underwent transcatheter embolization therapy of his splenic artery followed by splenectomy and right-sided orchiectomy. A computed tomography scan also showed metastasis to both lungs. During his last follow up after four cycles of cisplatin-based chemotherapy, the level of tumor markers had decreased, decreases in the size of his liver and pulmonary lesions were noted but new sclerotic lesions were evident in his thoracolumbar region raising concern for bony metastasis. Conclusions: Prognosis of testicular tumor depends mainly on the clinical stage, but emergence of a sarcomatous component presents a challenge in the treatment of germ cell tumors and the histological subtype of this component can be used as a guide to specific chemotherapy in these patients.
    [Show full text]
  • Metastatic Embryonal Carcinoma in the Maxillary Gingiva
    ANTICANCER RESEARCH 28 : 1181-1186 (2008) Metastatic Embryonal Carcinoma in the Maxillary Gingiva FRANCESCA ANGIERO 1 and MICHELE STEFANI 2 1Universit degli Studi di Milano-Bicocca, Facoltà di Medicina e Chirurgia Sezionàe Anatomia Patologica, Ospedale San Gerardo, Monza (Mi); 2Universit degli Studi di Milano Statale, Istituto di Anatomia Patologica Sezione Patologia Orale, Italy à Abstract . Gingival metastases from embryonal carcinoma are cavity (2-5) and that of seminoma, although rare, has been very rare and often associated with widespread disease and reported (6-13), mainly to the jaw bones. Some cases have poor prognosis. Because of their indistinct clinical appearance, also been reported of embryonal carcinoma metastasizing they may be difficult to discriminate from more frequent to the oral cavity (3, 14). gingival hyperplastic or reactive lesions. The case of a 35-year- Testicular germ cell tumors (GCTs) are a heterogeneous old man who presented with a swelling in the left maxillary group of tumors with diverse histopathology and clinical gingiva, extending from the first premolar to the second molar behavior. They originate from the male gonad and are is reported. This medical history revealed that, 2 years classified into two broad categories, namely seminoma and previously, he had been diagnosed with a testicular mixed germ non-seminomatous germ cell tumor (NSGCT). cell tumor (GCTs), for which he had undergone right inguinal Seminoma is the commonest type of testicular germ cell orchidectomy and chemotherapy, leading to complete tumor, accounting for approximately 50% of cases (15-17). remission. Histology revealed a metastatic embryonal There are two types of seminomatous tumor: (1) classic carcinoma.
    [Show full text]
  • Testicular Choriocarcinoma Metastatic to the Skin: an Additional Case and Literature Review Lily L
    Testicular Choriocarcinoma Metastatic to the Skin: An Additional Case and Literature Review Lily L. Tinkle, MD, PhD, Irvine, California LCDR Brad S. Graham, MC, USNR, Irvine, California Thomas J. Spillane, MD, Irvine, California Ronald J. Barr, MD, Irvine, California Choriocarcinoma, a malignancy of trophoblastic spleen, and adrenal glands.2 Skin metastases are un- cells, is characterized by the secretion of human common. To the best of our knowledge, only 14 cases chorionic gonadotropin (hCG). Choriocarcinoma have been reported in the literature since 1974, primarily arises from the fetal (placental) troph- 6 of which had skin metastases of testicular origin.1-5 oblasts in the setting of a molar pregnancy. Skin metastases in nongestational choriocarcinoma Nongestational choriocarcinoma from the ovary or coincide with visceral metastases and portend a poor testis is much rarer. Testicular choriocarcinoma is prognosis despite aggressive chemotherapy or surgical a malignant tumor with great propensity for distant intervention.1 A rare case of metastatic testicular metastasis. The primary sites of metastasis are the choriocarcinoma to the skin and viscera is presented. lungs, liver, and brain. Skin metastasis is very rare but portends a grave prognosis when diagnosed. Case Report We present the case of a 24-year-old white male A 24-year-old white male was admitted to our medical with a testicular mixed germ-cell tumor with skin center for the treatment of an enlarged left testicular metastases of choriocarcinoma. mass. Although the tumor had been present for 10 months, the patient had refused to seek medical horiocarcinoma is a malignant tumor of troph- treatment until just 2 weeks before hospital admis- oblastic cells.
    [Show full text]
  • Gonadoblastoma Overgrown by Dysgerminoma in Women with 46,XX Karyotype -A Report of Two Cases
    대한병리학회지: 제 37 권제1 호 2003 The Korean Journal of Pathology. 2003; 37: 66-70 Gonadoblastoma Overgrown by Dysgerminoma in Women with 46,XX Karyotype -A Report of Two Cases- Mi-Jung Kim∙Hee-Jeong Ahn1 Gonadoblastoma is a neoplasm containing an intimate mixture of germ cells and elements Ji-Young Kim1∙ Kyu-Rae Kim resembling immature granulosa or Sertoli cells. It has been considered as in situ germ cell malignancy that can be overgrown by more malignant germ cell neoplasms. The tumor has been reported to almost exclusively develop in various types of gonadal maldevelopment syn- Department of Pathology, University of dromes containing the Y chromosome, such as in pure or mixed gonadal dysgenesis and, less Ulsan College of Medicine, Asan commonly, in male hermaphroditism. However, occurrences in phenotypically and chromoso- Medical Center, Seoul, Korea; mally normal, menstruating women are exceptionally rare. We report two cases of gonadoblas- 1Department of Pathology, Bundang Hospital, College of Medicine Pochon toma overgrown by dysgerminoma occurring in the ovaries of phenotypically and cytogeneti- Cha University, Seongnam, Korea cally normal menstruating women. One of the two cases showed an area composed of granu- losa cell tumor-like elements. This type of combination has been very rarely described, and exemplified that gonadoblastoma may progress to sex cord-stromal tumors as well as to the malignant germ cell tumors. Received : June 28, 2002 Accepted : November 6, 2002 Corresponding Author Kyu-Rae Kim, M.D. Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Pungnap-dong, Songpa-gu, Seoul 138-736, Korea Tel: 02-3010-4514 Fax: 02-472-7898 Key Words : Gonadoblastoma-Dysgerminoma-Sex Cord-Stromal Tumor-Gonadal Dysgen- E-mail: [email protected] esis, 46,XX In 1953, Scully described gonadoblastoma as a separate enti- gonadoblastomas in the phenotypically and cytogenetically nor- ty.
    [Show full text]
  • Seminoma, Sertolioma, and Leydigoma in Dogs: Clinical and Morphological Correlations
    Bull Vet Inst Pulawy 56, 361-367, 2012 DOI: 10.2478/v10213-012-0063-8 SEMINOMA, SERTOLIOMA, AND LEYDIGOMA IN DOGS: CLINICAL AND MORPHOLOGICAL CORRELATIONS RAFAŁ CIAPUTA, MARCIN NOWAK, MACIEJ KIEŁBOWICZ¹, AGNIESZKA ANTOŃCZYK², KAROLINA BŁASIAK², AND JANUSZ A. MADEJ Department of Pathology, ¹Department of Surgery, ²Department of Reproduction and Clinic of Farm Animals, Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, 50-375 Wroclaw, Poland [email protected] Received: April 27, 2012 Accepted: September 7, 2012 Abstract The study aimed at presenting the most frequent male gonadal tumours in dogs, their clinical and histopathological aspects, at outlining aetiopathogenesis and differential diagnosis of the tumours. As examples of the most frequently manifested testicular tumours, three clinical cases were presented, involving tumour of interstitial (Leydig) cells, tumour of Sertoli cells, and seminoma. Respective clinical diagnosis employed USG, X-ray patterns, and morphological and biochemical tests. The surgically sampled material was stained with H+E and an attempt was made to establish expression of E-cadherin, calretinin, and Ki-67. It was shown that histopathological diagnosis of testicular tumours in dogs is frequently very difficult and complex and requires multidirectional studies. Key words: dogs, seminoma, sertolioma, leydigoma, calretinin, E-cadherin. Testicular tumours used to be encountered significant effect on the development of leydigomas (5, relatively frequently in household animals and the 34). lesions are most frequently noted in dogs (14, 19, 22, 23, An increased risk of testicular tumour 25, 35). On grounds of multi-year studies of Nielsen et development can be noted in morbid syndromes linked al.
    [Show full text]